KT
GSK icon

Kanaly Trust’s GSK GSK Stock Holding History

Kanaly Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.68M Sell
34,877
-11,161
-24% -$551K 0.36% 37
2016
Q3 		$2.48M Sell
46,038
-3,368
-7% -$185K 0.53% 25
2016
Q2 		$2.68M Buy
49,406
+2,216
+5% +$117K 0.54% 21
2016
Q1 		$2.39M Buy
47,190
+836
+2% +$41.6K 0.48% 23
2015
Q4 		$2.34M Sell
46,354
-1,215
-3% -$61.9K 0.48% 25
2015
Q3 		$2.29M Buy
47,569
+815
+2% +$42.4K 0.5% 23
2015
Q2 		$2.43M Buy
46,754
+3,540
+8% +$199K 0.48% 20
2015
Q1 		$2.49M Sell
43,214
-1,313
-3% -$75.3K 0.49% 17
2014
Q4 		$2.38M Buy
44,527
+6,203
+16% +$347K 0.48% 26
2014
Q3 		$2.2M Buy
38,324
+3,932
+11% +$241K 0.43% 28
2014
Q2 		$2.3M Buy
34,392
+6,773
+25% +$458K 0.42% 26
2014
Q1 		$1.84M Buy
27,619
+49
+0.2% +$3.31K 0.36% 36
2013
Q4 		$1.84M Buy
27,570
+21,029
+321% +$1.36M 0.37% 35
2013
Q3 		$410K Sell
6,541
-148
-2% -$9.53K 0.12% 65
2013
Q2 		$417K Buy
+6,689
New +$425K 0.13% 60

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kanaly Trust's GSK Position: Q4 2016 in Review

Kanaly Trust reduced its GSK (GSK) stake by 24% in Q4 2016, selling an estimated $551K and leaving 34,877 shares worth $1.68M. The position accounts for 0.36% of the portfolio, ranked #37.

Kanaly Trust first reported a position in GSK in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.68M in Q2 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Kanaly Trust held 34,877 shares of GSK worth $1.68M as of Q4 2016.
  • Kanaly Trust sold 11,161 GSK shares in Q4 2016, an estimated $551K.
  • GSK made up 0.36% of Kanaly Trust's portfolio in Q4 2016, its #37 holding.
  • Kanaly Trust first reported a position in GSK in Q2 2013 and has held it in 15 quarters since.
  • Kanaly Trust's GSK position peaked at $2.68M in Q2 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.